Background Cognitive symptoms are common in patients with Parkinson's disease. Characterization of a patient's cognitive profile is an essential step toward the identification of predictors of cognitive worsening. Objective The aim of this study was to investigate the use of the combination of resting-state EEG and data-mining techniques to build characterization models. Methods Dense EEG data from 118 patients with Parkinson's disease, classified into 5 different groups according to the severity of their cognitive impairments, were considered. Spectral power analysis within 7 frequency bands was performed on the EEG signals. The obtained quantitative EEG features of 100 patients were mined using 2 machine-learning algorithms to build and t...
OBJECTIVE: Mild cognitive impairment in Parkinson's disease (PD-MCI) is diagnosed based on the resul...
BackgroundParkinson’s disease (PD) often presents with subtle early signs, making diagnosis difficul...
Parkinson’s disease which is the second most prevalent neurodegenerative disorder in the United Stat...
Background Cognitive symptoms are common in patients with Parkinson's disease. Characterization of a...
Background Cognitive symptoms are common in patients with Parkinson's disease. Characterization of a...
Objective: A downside of Deep Brain Stimulation (DBS) for Parkinson's Disease (PD) is that cognitive...
Background: Parkinson’s disease (PD) affects 7–10 million people worldwide. Its diagnosis is clinica...
Background: Diagnosis of Parkinson’s disease (PD) is mainly based on motor symptoms and can be suppo...
There is growing interest in the potential of neuroimaging to help develop non-invasive biomarkers i...
Current tests of disease status in Parkinson's disease suffer from high variability, limiting their ...
Growing interest surrounds the use of electroencephalography (EEG) and deep learning for diagnosing ...
Medicine is a complex field with highly trained specialists with extensive knowledge that continuous...
BackgroundThere is a need for reliable and robust Parkinson's disease biomarkers that reflect severi...
The field of signal processing has many applications, one of which is in the field of biomedical eng...
Non-motor symptoms in Parkinson's disease (PD) involving cognition and emotion have been progressive...
OBJECTIVE: Mild cognitive impairment in Parkinson's disease (PD-MCI) is diagnosed based on the resul...
BackgroundParkinson’s disease (PD) often presents with subtle early signs, making diagnosis difficul...
Parkinson’s disease which is the second most prevalent neurodegenerative disorder in the United Stat...
Background Cognitive symptoms are common in patients with Parkinson's disease. Characterization of a...
Background Cognitive symptoms are common in patients with Parkinson's disease. Characterization of a...
Objective: A downside of Deep Brain Stimulation (DBS) for Parkinson's Disease (PD) is that cognitive...
Background: Parkinson’s disease (PD) affects 7–10 million people worldwide. Its diagnosis is clinica...
Background: Diagnosis of Parkinson’s disease (PD) is mainly based on motor symptoms and can be suppo...
There is growing interest in the potential of neuroimaging to help develop non-invasive biomarkers i...
Current tests of disease status in Parkinson's disease suffer from high variability, limiting their ...
Growing interest surrounds the use of electroencephalography (EEG) and deep learning for diagnosing ...
Medicine is a complex field with highly trained specialists with extensive knowledge that continuous...
BackgroundThere is a need for reliable and robust Parkinson's disease biomarkers that reflect severi...
The field of signal processing has many applications, one of which is in the field of biomedical eng...
Non-motor symptoms in Parkinson's disease (PD) involving cognition and emotion have been progressive...
OBJECTIVE: Mild cognitive impairment in Parkinson's disease (PD-MCI) is diagnosed based on the resul...
BackgroundParkinson’s disease (PD) often presents with subtle early signs, making diagnosis difficul...
Parkinson’s disease which is the second most prevalent neurodegenerative disorder in the United Stat...